Market Research Report
US Procedure Numbers for Orthopedic Biomaterials 2017 - MedPro
|Published by||iData Research Inc.||Product code||454942|
|Published||Content info||459 Pages
Delivery time: 1-2 business days
|US Procedure Numbers for Orthopedic Biomaterials 2017 - MedPro|
|Published: March 1, 2017||Content info: 459 Pages||
The full report suite on the U.S. market for orthopedic biomaterials includes bone graft substitutes, which is represented by allografts, demineralized bone matrix, and synthetic bone graft market. The report also includes orthopedic growth factors, cellular allografts, orthopedic cell therapy, hyaluronic acid viscosupplementation, orthopedic cartilage repair, and spinal machined bone allograft markets.
Segments Covered in this Orthopedic Biomaterials Procedure Volume Research
This market study focuses specifically on the volume of procedures in the orthopedic biomaterials market. It includes analysis of procedures in the following segments:
Bone Graft Substitute
Growth Factor Bone Grafts
Hyaluronic Acid Injections
Spinal Machined Bone Allografts
This data is then displayed over the forecast period, 2013-2023, outlining the exact growth rates for procedures in these segments. If you're interested in seeing the trends in procedures to formulate your market sizing and forecasts this is the most accurate and most affordable way to do it.
About Procedure Volume Research (MedPro)
Our analysts meticulously research for 3 to 4 months to put together a suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedPro is one portion of that analysis that outlines only the procedure volumes and forecasts for each market in that suite of reports.
This procedural analysis is incorporated in our market size analysis and forecasting which are available when purchasing a MedSuite, MedView or MedCore. For a deeper description on these product types click here or contact us to have a product consultant help you find the data you need.
Where Do We Get Orthopedic Biomaterials Procedure Data?
Our team of analysts has proprietary data that we've been collecting for over a decade as well as government and private databases like that from CMS and hospital records. By looking at multiple sources we are able to triangulate on orthopedic biomaterials procedure volumes that influence and coincide with our overall market sizing.
Trends Affecting the Orthopedic Biomaterials Market
The fastest growing segment in 2016 was the cellular allograft market. This high growth will be slowed due to budgetary constraints that are pushing hospitals to the cheaper allograft procedures. However, due to the therapeutic efficacy of stem cells, they provide greater osteoinductive and osteogenesis properties than other bone grafts, thus improving bone repair. Currently, their use is only considered for the spine, but the market may experience further growth if other indications become approved, such as with the foot where some patients may experience poor vascularization.
Questions This Report will Help You Answer
What is affecting the volume of procedures in the U.S.?
How many procedures were done in 2016?
How many procedures were done historically?
How many procedures can we expect in 2023 and what is the growth trend?